Issues: Vax Specific

Anthrax

Hepatitis B

Hib

HPV

Influenza

Lyme Disease
Meningococcal

MMR    

Polio

Rotavirus

● Smallpox

Tdap/Td

Varicella

Yellow Fever

 

Issues: Misc

Exemptions

Legislation 

New Vax Status

Thimerosal

Independent Vax  Safety Board

 

Vaccine Info

2011 Schedule

ACIP Recs

Components
IOM Reports

● Vax Injury Comp Program
Manufacturer Links

Package Inserts

Reporting AEs

Thimerosal Table

VAERS

VISs

 

Links
 

Search
 

About IVS

Faculty Biographies

Publications

Donations

 

Email IVS

 

Disclaimers & Privacy
 

 

Institute for Vaccine Safety

Johns Hopkins Bloomberg School of Public Health

615 N. Wolfe Street

Room W5041

Baltimore, MD 21205

www.vaccinesafety.edu

 

 

 

 

Components of
Smallpox Vaccine
Excipients Table
Allergens Table
Components Table
 

Indication

Active immunity against vaccinia and smallpox

Proprietary Name

ACAM2000

Manufacturer

Sanofi Pasteur

Viability

Live attenuated

Microorganism

Vaccinia virus. Note: This vaccine does not contain smallpox virus (variola) and cannot spread or cause smallpox.

Approved Ages

All age groups link to approval letter

Dose

0.0025 mL administered using 15 jabs of a bifurcated needle dipped into the vaccine

Route

Percutaneous (scarification)

Appearance

Clear to slightly hazy, colorless to straw-colored

Concentration

2.5 x 105 plaque-forming units 

Excipients

HEPES, 6-8 mM

Human serum albumin, 2%

Sodium chloride, 0.5 – 0.7%

Mannitol, 5%

Neomycin, trace amounts

Polymyxin B, trace amounts 

Adjuvant

None

Allergens

Neomycin, trace amounts

Polymyxin B, trace amounts

Preservatives

Phenol 0.25%

Media

African Green Monkey kidney (Vero) cells

Packaging

Vials, multiple-dose 3 mL clear glass vials containing lyophilized powder

Diluent, in 3 mL clear glass vials containing 0.6 mL of diluent

Routine Storage

2 to 8° C

Shipped at 0° C or cooler

Package Insert updated

September 2009

updated January 2012

This page was last updated on January 23, 2012

© 2012 Institute for Vaccine Safety